Clinical Trial Update: Immunointervention With Calcitriol in New-Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating calcitriol as an immunointervention in new-onset Type 1 diabetes has been completed. The study was sponsored by Institut fur Diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Calcitriol (calcitriol)

Snippet

Sponsor: Institut fur Diabetesforschung, Munich, Germany | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED